These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3741725)

  • 21. Retrospective evaluation of a possible interaction between warfarin and levofloxacin.
    McCall KL; Scott JC; Anderson HG
    Pharmacotherapy; 2005 Jan; 25(1):67-73. PubMed ID: 15767222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects.
    Desai A; Yamazaki T; Dietz AJ; Kowalski D; Lademacher C; Pearlman H; Akhtar S; Townsend R
    Clin Pharmacol Drug Dev; 2017 Jan; 6(1):86-92. PubMed ID: 27278712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Warfarin sensitivity after mechanical heart valve replacement.
    Rose JP; Rihn TL; Long SF
    Pharmacotherapy; 1998; 18(4):856-9. PubMed ID: 9692661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and pharmacodynamics of warfarin at steady state.
    Routledge PA; Chapman PH; Davies DM; Rawlins MD
    Br J Clin Pharmacol; 1979 Sep; 8(3):243-7. PubMed ID: 497091
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of allopurinol on drug metabolism in man.
    Rawlins MD; Smith SE
    Br J Pharmacol; 1973 Aug; 48(4):693-8. PubMed ID: 4788211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Interaction between warfarin and nalidic acid].
    Gulløv AL; Koefoed BG; Petersen P
    Ugeskr Laeger; 1996 Sep; 158(37):5174-5. PubMed ID: 8848852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levofloxacin and warfarin interaction.
    Jones CB; Fugate SE
    Ann Pharmacother; 2002 Oct; 36(10):1554-7. PubMed ID: 12243605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of Tramadol Coadministration on Prothrombin Time-International Normalized Ratio in Patients Receiving Warfarin].
    Hosono T; Kondo A; Kambayashi Y; Homma M
    Yakugaku Zasshi; 2017; 137(8):999-1003. PubMed ID: 28768953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of carbamazepine on warfarin anticoagulation: a register-based nationwide cohort study involving the Swedish population.
    Mannheimer B; Andersson ML; Järnbert-Pettersson H; Lindh JD
    J Thromb Haemost; 2016 Apr; 14(4):765-71. PubMed ID: 26792124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2C9 genotypes and dose requirements during the induction phase of oral anticoagulant therapy.
    Peyvandi F; Spreafico M; Siboni SM; Moia M; Mannucci PM
    Clin Pharmacol Ther; 2004 Mar; 75(3):198-203. PubMed ID: 15001971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between warfarin and propranolol.
    Scott AK; Park BK; Breckenridge AM
    Br J Clin Pharmacol; 1984 May; 17(5):559-64. PubMed ID: 6733003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between chromogenic factor X and international normalized ratio differs during early warfarin initiation compared with chronic warfarin administration.
    Rosborough TK; Jacobsen JM; Shepherd MF
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):433-5. PubMed ID: 19543077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of pharmacokinetic and pharmacodynamic interactions when lenalidomide is co-administered with warfarin in a randomized clinical trial setting.
    Weiss D; Knight R; Zhou S; Palmisano M; Chen N
    Clin Drug Investig; 2015 Jul; 35(7):455-61. PubMed ID: 26024727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of warfarin kinetics in man associated with exposure to an operating-room environment.
    Ghoneim MM; Delle M; Wilson WR; Ambre JJ
    Anesthesiology; 1975 Sep; 43(3):333-6. PubMed ID: 1163833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common genetic variants of microsomal epoxide hydrolase affect warfarin dose requirements beyond the effect of cytochrome P450 2C9.
    Loebstein R; Vecsler M; Kurnik D; Austerweil N; Gak E; Halkin H; Almog S
    Clin Pharmacol Ther; 2005 May; 77(5):365-72. PubMed ID: 15900282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Warfarin interactions with antibiotics in the ambulatory care setting.
    Clark NP; Delate T; Riggs CS; Witt DM; Hylek EM; Garcia DA; Ageno W; Dentali F; Crowther MA;
    JAMA Intern Med; 2014 Mar; 174(3):409-16. PubMed ID: 24445404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimizing the dose of three-factor prothrombin complex concentrate in traumatic brain injury patients on warfarin therapy.
    Huynh TK; Costello JL; Rebuck JA
    Pharmacotherapy; 2014 Mar; 34(3):260-4. PubMed ID: 24338807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced elimination of warfarin during treatment with cholestyramine.
    Jähnchen E; Meinertz T; Gilfrich HJ; Kersting F; Groth U
    Br J Clin Pharmacol; 1978 May; 5(5):437-40. PubMed ID: 656283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation.
    Bianco TM; Bussey HI; Farnett LE; Linn WD; Roush MK; Wong YW
    Pharmacotherapy; 1992; 12(6):435-9. PubMed ID: 1492006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Successful Case of a Patient Undergoing Warfarin and S-1 Therapy Using Internet-based Control of Home-measured PT-INR.
    Yamamura K; Yano K; Hirooka Y; Hirashiki A; Murohara T; Yamada K
    Yakugaku Zasshi; 2015; 135(7):925-7. PubMed ID: 25913669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.